New Enterprise Associates 17, L.P.

13D and 13G Filings

13D/G filings
13D on 6 securities
Location
Timonium, MD
CIK
0001768564
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Monte Rosa Therapeutics, Inc. 13D/A Amendment 4
GLUE · 61225M102
7.9% 7/6/2026
Event 7/1/2026
Inventiva S.A. 13D/A Amendment 4
IVA · 46124U107
4.9% 4/1/2026
Event 3/30/2026
Monte Rosa Therapeutics, Inc. 13D/A Amendment 3
GLUE · 61225M102
9.7% 3/19/2026
Event 3/17/2026
Korro Bio, Inc. 13D/A Amendment 2
KRRO · 500946108
9.9% 3/12/2026
Event 3/10/2026
SpyGlass Pharma, Inc. 13D
SGP · 85220G109
22.2% 2/13/2026
Event 2/9/2026
MBX Biosciences, Inc. 13D/A Amendment 1
MBX · 55287L101
8.1% 11/10/2025
Event 11/6/2025
NeueHealth, Inc. 13D/A Amendment 9
NEUE · 10920V404
0% 10/6/2025
Event 10/2/2025
Inventiva S.A. 13D/A Amendment 3
IVA · 46124U107
6.0% 5/7/2025
Event 5/7/2025
NeueHealth, Inc. 13D/A Amendment 8
NEUE · 10920V404
57.0% 12/26/2024
Event 12/23/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.